Data / Form D filings / RESPIRICS INC
RESPIRICS INC: Form D filings
RESPIRICS INC, a pharmaceuticals company in Raleigh, NC, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on August 27, 2010, reports $146,257 sold of a $146,257 offering to 13 investors.
Find out what RESPIRICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6008 TRIANGLE DR STE 101, Raleigh, NC, 27617
- Phone
- (919) 789-4220
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1287016
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2010 | New notice | $146,257 | $146,257 | $0 | 13 | Aug 27, 2010 | sec.gov |
| May 4, 2010 | New notice | $4,639,200 | $3,726,283 | $912,917 | 50 | Apr 16, 2010 | sec.gov |
| Sep 11, 2009 | New notice | $1,500,000 | $375,000 | $1,125,000 | 10 | Apr 16, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| R. Brent Dixon | Director | |
| James R. Butler | Director | |
| Robert A. Casper | Director | |
| John Q. Adams, Sr. | Director | |
| Mark Celeste | Executive Officer, Director | |
| Lary Snodgrass | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Aug 23, 2010 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RESPIRICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.